Insider Transactions in Q3 2018 at Constellation Pharmaceuticals Inc (CNST)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 23
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+19.31%
|
$3,000,000
$15.0 P/Share
|
|
Jul 23
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
635,842
+50.0%
|
-
|
|
Jul 23
2018
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+19.31%
|
$3,000,000
$15.0 P/Share
|
|
Jul 23
2018
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
635,843
+50.0%
|
-
|
|
Jul 23
2018
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
504,743
+50.0%
|
-
|
|
Jul 23
2018
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
266,667
+30.33%
|
$4,000,005
$15.0 P/Share
|
|
Jul 23
2018
|
Column Group L P > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
79,155
+50.0%
|
-
|
|
Jul 23
2018
|
Column Group L P > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,666,888
+49.94%
|
-
|
|
Jul 23
2018
|
Regents Of The University Of California |
BUY
Open market or private purchase
|
Direct |
133,333
+5.49%
|
$1,999,995
$15.0 P/Share
|
|
Jul 23
2018
|
Regents Of The University Of California |
BUY
Conversion of derivative security
|
Direct |
2,164,073
+50.0%
|
-
|